- Home
- TSBK vs ABEO Comparison
TSBK vs ABEO Comparison
Compare TSBK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- ABEO
- Stock Information
- Founded
- TSBK 1915
- ABEO N/A
- Country
- TSBK United States
- ABEO United States
- Employees
- TSBK N/A
- ABEO N/A
- Industry
- TSBK Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- ABEO Health Care
- Exchange
- TSBK Nasdaq
- ABEO Nasdaq
- Market Cap
- TSBK 229.3M
- ABEO 243.9M
- IPO Year
- TSBK 1998
- ABEO 1980
- Fundamental
- Price
- TSBK $29.00
- ABEO $6.55
- Analyst Decision
- TSBK
- ABEO Strong Buy
- Analyst Count
- TSBK 0
- ABEO 3
- Target Price
- TSBK N/A
- ABEO $18.00
- AVG Volume (30 Days)
- TSBK 13.5K
- ABEO 263.3K
- Earning Date
- TSBK 10-28-2024
- ABEO 11-11-2024
- Dividend Yield
- TSBK 3.35%
- ABEO N/A
- EPS Growth
- TSBK N/A
- ABEO N/A
- EPS
- TSBK 3.03
- ABEO N/A
- Revenue
- TSBK $74,387,000.00
- ABEO N/A
- Revenue This Year
- TSBK N/A
- ABEO N/A
- Revenue Next Year
- TSBK N/A
- ABEO $7,097.06
- P/E Ratio
- TSBK $9.37
- ABEO N/A
- Revenue Growth
- TSBK N/A
- ABEO 147.52
- 52 Week Low
- TSBK $23.93
- ABEO $3.05
- 52 Week High
- TSBK $32.24
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- TSBK 45.02
- ABEO 64.53
- Support Level
- TSBK $28.16
- ABEO $6.39
- Resistance Level
- TSBK $29.50
- ABEO $6.74
- Average True Range (ATR)
- TSBK 0.60
- ABEO 0.31
- MACD
- TSBK -0.19
- ABEO 0.03
- Stochastic Oscillator
- TSBK 25.23
- ABEO 70.95
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.